Literature DB >> 16281608

Keloids--clinical diagnosis, pathogenesis, and treatment options.

Alexander G Marneros1, Thomas Krieg.   

Abstract

Keloids are defined as excessive scar tissue formation extending beyond the area of the original skin injury and occurring in predisposed individuals. They are considered to be a result of abnormal wound healing. The pathogenetic mechanisms that cause keloids remain unknown. Experiments with cells derived from keloid tissue revealed a number of abnormalities in cellular functions, such as in proliferation, apoptosis, or expression of growth factors and extracellular matrix proteins. Furthermore, several studies have reported altered keratinocyte-fibroblast interactions in keloids. Despite the diverse pathological changes in cellular functions and expression profiles of cells derived from keloid tissue, recent genetic studies have provided evidence that single genes may act as major regulators of keloid formation. We provide an overview of the pathogenetic mechanisms of keloid formation in the context of their clinical characteristics and current therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16281608     DOI: 10.1046/j.1439-0353.2004.04077.x

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


  37 in total

1.  A genome-wide association study identifies four susceptibility loci for keloid in the Japanese population.

Authors:  Mitsuko Nakashima; Suyoun Chung; Atsushi Takahashi; Naoyuki Kamatani; Takahisa Kawaguchi; Tatsuhiko Tsunoda; Naoya Hosono; Michiaki Kubo; Yusuke Nakamura; Hitoshi Zembutsu
Journal:  Nat Genet       Date:  2010-08-15       Impact factor: 38.330

2.  Keloids: pathogenesis, clinical features, and management.

Authors:  Chuma J Chike-Obi; Patrick D Cole; Anthony E Brissett
Journal:  Semin Plast Surg       Date:  2009-08       Impact factor: 2.314

3.  Chemokine-like factor 1: A promising therapeutic target in human diseases.

Authors:  Xiaopeng Cai; Jingwen Deng; Qianqian Ming; Huiqiang Cai; Zhi Chen
Journal:  Exp Biol Med (Maywood)       Date:  2020-07-26

4.  Keloid of the conjunctiva simulating a conjunctival malignancy.

Authors:  Jignesh G Parikh; Rahul N Khurana; Michael M Lai; Anthony Rodriguez; Narsing A Rao
Journal:  Br J Ophthalmol       Date:  2007-09       Impact factor: 4.638

5.  siRNA knockdown of tissue inhibitor of metalloproteinase-1 in keloid fibroblasts leads to degradation of collagen type I.

Authors:  Masayo Aoki; Koichi Miyake; Rei Ogawa; Teruyuki Dohi; Satoshi Akaishi; Hiko Hyakusoku; Takashi Shimada
Journal:  J Invest Dermatol       Date:  2013-09-16       Impact factor: 8.551

6.  Management of pediatric penile keloid.

Authors:  Michael Yong; Kourosh Afshar; Andrew Macneily; Jugpal S Arneja
Journal:  Can Urol Assoc J       Date:  2013 Sep-Oct       Impact factor: 1.862

7.  An intra-individual surgical wound comparison shows that octenidine-based hydrogel wound dressing ameliorates scar appearance following abdominoplasty.

Authors:  Johannes Matiasek; Philip Kienzl; Lukas W Unger; Christoph Grill; Rupert Koller; Bela R Turk
Journal:  Int Wound J       Date:  2018-06-29       Impact factor: 3.315

Review 8.  [Therapy of keloids].

Authors:  S Karrer
Journal:  Hautarzt       Date:  2007-11       Impact factor: 0.751

Review 9.  Up-to-date approach to manage keloids and hypertrophic scars: a useful guide.

Authors:  Anna I Arno; Gerd G Gauglitz; Juan P Barret; Marc G Jeschke
Journal:  Burns       Date:  2014-04-24       Impact factor: 2.744

10.  Hypertrophic Scars: Are Vitamins and Inflammatory Biomarkers Related with the Pathophysiology of Wound Healing?

Authors:  Inês Correia-Sá; Paula Serrão; Marisa Marques; Maria A Vieira-Coelho
Journal:  Obes Surg       Date:  2017-12       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.